Anti-TGF-beta monoclonal antibody 2G7

Drug Profile

Anti-TGF-beta monoclonal antibody 2G7

Alternative Names: Anti-TGF-beta 2G7; Anti-TGF-beta antibody 2G7; Anti-transforming growth factor-beta monoclonal antibody 2G7

Latest Information Update: 15 Aug 2002

Price : $50

At a glance

  • Originator Genentech
  • Developer Genentech; Nonindustrial source
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Transforming growth factor beta inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top